Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The combination of metronidazole and doxycycline is used to treat various infections, particularly when broader antimicrobial coverage is needed. This combination leverages the distinct mechanisms of action of both antibiotics to provide enhanced efficacy against a range of pathogens. ## Pharmacology and Mechanism of Action Metronidazole is a nitroimidazole antibiotic that works against anaerobic bacteria and certain parasites. It functions by entering bacterial cells and being reduced by bacterial enzymes to form reactive compounds that damage bacterial DNA. Doxycycline is a tetracycline antibiotic that inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, preventing the attachment of aminoacyl-tRNA to the mRNA-ribosome complex. When used together, these antibiotics provide complementary coverage: - Doxycycline targets a wide range of gram-positive and gram-negative bacteria - Metronidazole specifically targets anaerobic bacteria and certain parasites ## Clinical Applications The metronidazole and doxycycline combination is used in several clinical scenarios: 1. **Pelvic Inflammatory Disease (PID)**: The combination of ceftriaxone, doxycycline, and metronidazole is recommended for treating PID. The 2021 CDC guidelines update specifically recommends adding metronidazole to ceftriaxone and doxycycline for women with mild-to-moderate PID. 2. **Dermatological Infections**: This combination may be used for treating certain skin conditions, particularly when multiple causative factors are present or when monotherapy has proven ineffective. For instance, in treating hidradenitis suppurativa, the combination has shown significant decreases in lesions and improvements in patients' quality of life. 3. **H. pylori Infections**: Metronidazole and tetracycline (a related antibiotic to doxycycline) are used together with bismuth compounds and proton pump inhibitors to treat H. pylori infections. ## Side Effects and Considerations When using metronidazole and doxycycline in combination, several important considerations should be noted: 1. **Increased Risk of Candida Colonization**: The combination significantly increases gastrointestinal and vaginal colonization by Candida species compared to either antibiotic alone. 2. **Gastrointestinal Side Effects**: Patients may experience an increased risk of gastrointestinal side effects like nausea, vomiting, and diarrhea when taking both antibiotics simultaneously. 3. **Alcohol Interaction**: Patients should avoid alcohol while taking metronidazole and for 3 days after stopping it, as this combination can cause a serious reaction. 4. **Photosensitivity**: Doxycycline can cause increased sensitivity to sunlight, which may be a consideration when using the combination. The combination of metronidazole and doxycycline provides broader antimicrobial coverage than either agent alone, making it valuable for treating complex infections with multiple pathogens or when monotherapy has failed.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Metronidazole and Doxycycline combination.